Advancing CAR T Cell Therapy for Brain Tumors: Overcoming Barriers to Efficacy
Christine Brown· Beckman Research Institute of City of Hope
Gladstone-UCSF Institute of Genomic Immunology Seminar by Christine Brown, PhD (Deputy Director, T Cell Therapeutics Research Laboratories) on developing and refining redirected CAR T cells for malignant brain tumors, including glioblastoma, tumor heterogeneity, immunosuppressive microenvironments, delivery routes, and manufacturing.
Ended
Tue, Aug 25 · 17:00 UTC · Mahley Auditorium & Online (Zoom)
OncologyCancer Biology